Enzon Inc (QX) (ENZN)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ENZN market cap is 9.41M. The company's latest EPS is USD 0.0013 and P/E is 100.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 207k | 52k | 701k | 26k | 0 |
| Operating Income | -973k | -1.31M | -469k | -1.03M | -1.04M |
| Net Income | -979k | -1.77M | -2.49M | -1.46M | 98k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.48M | 48.23M | 47.75M | 47.59M | 47.7M |
| Total Liabilities | 423k | 412k | 403k | 1.7M | 1.71M |
| Total Equity | 6.06M | 7.36M | 4.87M | 3.41M | 3.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 6.91M | -380k | -501k | -659k | 1.31M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -7.96M | 44.05M | N/A | N/A | -1.28M |
| Market Cap | 9.41M |
| Price to Earnings Ratio | 100.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 74.21M |
| Average Volume (1 week) | 240.07k |
| Average Volume (1 Month) | 102.47k |
| 52 Week Change | 51.01% |
| 52 Week High | 0.24 |
| 52 Week Low | 0.06 |
| Spread (Intraday) | 0.06 (39.41%) |
| Company Name | Enzon Inc (QX) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.enzon.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
